SCS departments and LAS navigation

Jeffrey A. Hubbell

photo Jeffrey A. HubbellJeffrey Hubbell was born in Kansas City, Missouri.  He received his Bachelor of Science degree from Kansas State University in 1982, and his doctorate from Rice University in 1986, both in chemical engineering. He was assistant then associate professor of chemical engineering at the University of Texas, Austin, from 1986-1994, and professor of chemical engineering at the California Institute of Technology from 1995-1997.

Hubbell next moved to Switzerland, where he initially served as a professor of biomedical engineering and director of the Institute for Biomedical Engineering at the Swiss Federal Institute of Technology and the University of Zurich. In 2003 he moved to École Polytechnique Fédérale de Lusanne (EPFL) to serve as founding director of the Institute of Bioengineering.
In February 2010, Prof. Hubbell was elected to the prestigious National Academy of Engineering, the first EPFL Professor to enter the US-based institution in his field.  He is the former president of the Society for Biomaterials, and is an elected fellow of Biomaterials Science and Engineering, the American Association for the Advancement of Science, and the American Institute of Medical and Biological Engineering.

Earlier in his career, Prof. Hubbell received the W.J. Kolff Award for Outstanding Research from the American Society of Artificial Internal Organs, the Outstanding Dow Young Faculty Award from the American Society of Engineering Education, and the National Science Foundation’s Presidential Young Investigator Award.

Hubbell's laboratory is directed toward biomaterials issues in tissue engineering, cell-based therapies, drug delivery, and medical devices. It involves polymer chemistry and cell biology ultimately directed toward altering some medical outcome. Current research addresses means by which the recognition of biological and synthetic polymers may be controlled, for example means by which to use polymers to block recognition in wound healing and immunity, by which to incorporate protein-like structures into synthetic materials, and by which to endow synthetic materials with the ability to be degraded by the cellular processes involved in tissue remodeling. Current clinical targets are cardiovascular implants and healing, nerve regeneration, post-surgical healing, and general aspects of the controlled delivery of proteins and genes.

School of Chemical Sciences
106 Noyes Lab
505 S. Mathews
Urbana, IL  61801
Professor Jonathan Sweedler

(217) 333-5070
(217) 333-3120 fax
jsweedle [at] illinois [dot] edu
Please send comments and suggestions to:
scs-webmaster [at] illinois [dot] edu